{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-298155","form_type":"8-K","ticker":"XOMA","cik":"0000791908","company_name":"XOMA Royalty Corp","filed_at":"2023-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.015471+00:00","generated_at":"2026-06-07T10:57:02.889128+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"XOMA secures up to $140M non-dilutive royalty-backed loan from Blue Owl at 9.875%","bullets":["XOMA draws $130M initial term loan; can draw additional $10M if VABYSMO royalties exceed threshold by March 2026.","Semi-annual interest at 9.875% fixed; 15-year maturity with optional prepayment; loan is non-recourse to XOMA assets.","Issued Blue Owl warrants for 120,000 shares in three tranches at $35, $42.50, and $50 per share (122%-217% premium).","Proceeds to fund stock repurchases and additional royalty/milestone acquisitions, per CIO Brad Sitko.","Loan backed by VABYSMO (faricimab) royalties; XOMA acquired these royalties for $14M in 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-298155","json":"https://secwatch.observer/filing/0001193125-23-298155.json","markdown":"https://secwatch.observer/filing/0001193125-23-298155.md","text":"https://secwatch.observer/filing/0001193125-23-298155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791908/000119312523298155/0001193125-23-298155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791908/000119312523298155/d669381d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T10:57:02.889128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"890174f637d27cdbd5792f940dfc8c628b3910d3","claim":"XOMA Royalty Corp incurred credit facility of up to $140 million with Blue Owl Capital Inc. at 9.875% per annum maturing December 15, 2038.","evidence_excerpt":"dated December 15, 2023, with the lenders from time to time party thereto (the “ Lenders ”) and Blue Owl Capital Corporation, as administrative agent (the “ Administrative Agent ”), pursuant to which the lenders extended certain senior secured credit facilities to the Subsidiary (the “ Loan ”) in an aggregate principal amount of up to $140 million (the “ Loan Amount ”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312523298155/0001193125-23-298155-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"up to $140 million"},{"label":"Counterparty","value":"Blue Owl Capital Inc."},{"label":"Rate","value":"9.875% per annum"},{"label":"Maturity","value":"December 15, 2038"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"390b5534c73aa4b51239a2372ec71dd6d5674db5","claim":"XOMA Royalty Corp entered into Warrants with Blue Owl Capital Inc. valued at warrants to purchase up to 120,000 shares of common stock at exercise prices of $35.00, $42.50, and (effective 2023-12-15).","evidence_excerpt":"XOMA also issued to Blue Owl warrants (the “ Warrants ”), to purchase (i) up to 40,000 shares of XOMA’s common stock, par value $0.0075 (“ Common Stock ”) at an exercise price of $35.00 per share, the form of which is attached to this Current Report on Form 8-K as Exhibit 4.1; (ii) up to 40,000 shares of Common Stock at an exercise price of $42.50 per share, the form of which is attached to this Current Report on Form 8-K as Exhibit 4.2; and (iii) up to 40,000 shares of Common Stock at an exercise price of $50.00 per share, the form of which is attached to this Current Report on Form 8-K as Exhibit 4.3.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312523298155/0001193125-23-298155-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Blue Owl Capital Inc."},{"label":"Value","value":"warrants to purchase up to 120,000 shares of common stock at exercise prices of $35.00, $42.50, and"},{"label":"Effective","value":"2023-12-15"}],"fact_type":"material_agreement"},{"claim_id":"6a1ee4b257f5457642123525ea684fd73e9ea627","claim":"XOMA Royalty Corp entered into Loan Agreement with Blue Owl Capital Corporation valued at up to $140 million principal amount; interest rate 9.875% per annum; maturity December 15, 2038 (effective 2023-12-15).","evidence_excerpt":"On December 15, 2023, XOMA Corporation (“ XOMA ”), through XRL 1 LLC, a newly formed, wholly-owned subsidiary (the “ Subsidiary ”), entered into a non-dilutive, non-recourse, royalty-backed loan for up to $140 million of capital (the “ Royalty Financing ”) with certain funds managed by the credit platform of Blue Owl Capital Inc. (collectively, “ Blue Owl ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312523298155/0001193125-23-298155-index.htm","confidence":0.98,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Blue Owl Capital Corporation"},{"label":"Value","value":"up to $140 million principal amount; interest rate 9.875% per annum; maturity December 15, 2038"},{"label":"Effective","value":"2023-12-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}